Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma
Article in Cancer and Metastasis Reviews (February 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Cancer and Metastasis Reviews (February 2024)
Article in Food & Function (March 2023)
Article in Clinical Reviews in Allergy & Immunology (October 2022)